ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,038.71
      1.08%
      US Tech 100
      21,205.20
      0.03%
      Dow Jones
      43,311.20
      0.03%
      Brent Oil
      72.99
      -0.40%
      Bitcoin
      95,568.77
      -3.76%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Nuvectis Pharma Inc (NVCT) Quote

      Nuvectis Pharma Inc

      Nuvectis Pharma Inc (NVCT)

      NASDAQ
      4.755
      0.105
      ( 2.26% )
      Updated: 13:32:16
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      4.755
      Bid
      4.72
      Ask
      4.78
      Volume
      51,605
      4.55 Day's Range 4.85
      4.44 52 Week Range 12.10
      Market Cap
      91.871M
      Previous Close
      4.65
      Open
      4.72
      Last Trade
      3
      @
      4.78
      Last Trade Time
      13:35:30
      Financial Volume
      $ 246,525
      VWAP
      4.7771
      Average Volume (3m)
      180,558
      Shares Outstanding
      19,320,973
      Dividend Yield
      -
      PE Ratio
      -4.14
      Earnings Per Share (EPS)
      -1.15
      Revenue
      -
      Net Profit
      -22.26M

      About Nuvectis Pharma Inc

      Nuvectis Pharma Inc is a biopharmaceutical company. Nuvectis Pharma Inc is a biopharmaceutical company.

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.nuvectis.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Nuvectis Pharma Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker NVCT. The last closing price for Nuvectis Pharma was $4.65. Over the last year, Nuvectis Pharma shares have traded in a share price range of $ 4.44 to $ 12.10.

      Nuvectis Pharma currently has 19,320,973 shares outstanding. The market capitalization of Nuvectis Pharma is $89.84 million. Nuvectis Pharma has a price to earnings ratio (PE ratio) of -4.14.

      Ask ADVFN Intelligence (AI)

      NVCT Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      November 20 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 08 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      November 05 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      November 05 2024
      Edgar (US Regulatory)

      PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

      Nuvectis Pharma (NASDAQ: NVCT) continues to make strides in precision oncology, gaining momentum following presentations last week at the AACR-NCI-EORTC Symposium where its drug candidate NXP900...

      October 28 2024
      Business Wire

      PESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to Watch

      With its focus on targeting well-defined subgroups by inhibiting SRC/YES1 kinases in Non Small-Cell Lung Cancer patients resistant to EGFR and ALK targeted therapies, Nuvectis Pharma’s NXP900...

      September 16 2024
      Business Wire

      Form 8-K - Current report

      August 29 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 06 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 06 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      June 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.005-0.1050420168074.764.954.441033824.58660818CS
      4-0.465-8.908045977015.225.47994.44928764.7835518CS
      12-1.505-24.04153354636.2611.84.441805586.78049595CS
      26-2.455-34.04993065197.2111.84.441295846.72044732CS
      52-3.755-44.1245593428.5112.14.441122037.19228803CS
      1560.80520.37974683543.9520.923.081888637.84114017CS
      2600.80520.37974683543.9520.923.081888637.84114017CS

      NVCT - Frequently Asked Questions (FAQ)

      What is the current Nuvectis Pharma share price?
      The current share price of Nuvectis Pharma is $ 4.755
      How many Nuvectis Pharma shares are in issue?
      Nuvectis Pharma has 19,320,973 shares in issue
      What is the market cap of Nuvectis Pharma?
      The market capitalisation of Nuvectis Pharma is USD 89.84M
      What is the 1 year trading range for Nuvectis Pharma share price?
      Nuvectis Pharma has traded in the range of $ 4.44 to $ 12.10 during the past year
      What is the PE ratio of Nuvectis Pharma?
      The price to earnings ratio of Nuvectis Pharma is -4.14
      What is the reporting currency for Nuvectis Pharma?
      Nuvectis Pharma reports financial results in USD
      What is the latest annual profit for Nuvectis Pharma?
      The latest annual profit of Nuvectis Pharma is USD -22.26M
      What is the registered address of Nuvectis Pharma?
      The registered address for Nuvectis Pharma is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
      What is the Nuvectis Pharma website address?
      The website address for Nuvectis Pharma is www.nuvectis.com
      Which industry sector does Nuvectis Pharma operate in?
      Nuvectis Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      AIREreAlpha Tech Corporation
      $ 3.425
      (150.00%)
      		108.45M
      SPRCSciSparc Ltd
      $ 0.4904
      (121.70%)
      		221.83M
      MGIHMillennium Group International Holdings Ltd
      $ 3.095
      (102.29%)
      		72.56M
      BCGBinah Capital Group Inc
      $ 3.81
      (92.42%)
      		8.08M
      ZCARZoomcar Holdings Inc
      $ 2.69
      (88.11%)
      		56.24M
      LNKSLinkers Industries Ltd
      $ 2.94
      (-69.34%)
      		1.61M
      BAOSBaosheng Media Group Holdings Ltd
      $ 4.22
      (-40.56%)
      		1.52M
      GTIGraphjet Technology
      $ 0.4268
      (-30.03%)
      		15.53M
      NEUPNeuphoria Therapeutics Inc
      $ 4.65
      (-29.86%)
      		502.08k
      SVRESaverOne 2014 Ltd
      $ 1.0801
      (-28.47%)
      		1.1M
      SPRCSciSparc Ltd
      $ 0.4904
      (121.70%)
      		221.83M
      XTIAXTI Aerospace Inc
      $ 0.0401
      (2.30%)
      		201.34M
      COEPCoeptis Therapeutics Holdings Inc
      $ 0.2081
      (46.55%)
      		193.12M
      RGTIRigetti Computing Inc
      $ 14.4126
      (26.98%)
      		158.83M
      SMXSMX Security Matters Public Company
      $ 0.35
      (60.55%)
      		157.23M

      NVCT Discussion

      View Posts
      gail gail 1 month ago
      grabbed some on the dip
      👍️0
      Monksdream Monksdream 4 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 6 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 8 months ago
      NVCT under $10
      👍️0
      Monksdream Monksdream 10 months ago
      NVCT 10Q due March 6
      👍️0
      Monksdream Monksdream 12 months ago
      NVCT a bounce
      👍️0
      conix conix 3 years ago
      NVCT HIGHLIGHTS:

      *Recently completed Initial Public Offering - $5.00 Per share
      *2 Precision Cancer medicines in development - ovarian and triple negative breast
      *Data flow throughout 2022
      *CEO with multiple success stories in life science sector to $billion dollar market caps
      *Analysts project a $66 billion precision medicines market for 2021; In 6 years, this number is expected to top $140 billion

      Nuvectis Pharma Inc - Company Background:

      Nuvectis Pharma, Inc. is a biopharmaceutical company focused on the development of innovative precision medicines for serious conditions of unmet medical need in oncology. The Company is currently developing two drug candidates: NXP800, a clinical-stage HSF1 pathway inhibitor currently in a Phase 1 study in patients with advanced solid tumors, and NXP900, a novel SRC/YES1 kinase inhibitor currently in preclinical development with IND-enabling studies ongoing.

      Market Capitalization: $225 million
      Range - 52 week: $3.08 - $20.75
      Current Price: $20.44
      Trades on: Nasdaq Capital Market
      Ticker Symbol: NVCT

      website: nuvectis.com
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      wow from $3 to almost $21
      👍️0
      ipo_dude ipo_dude 3 years ago
      $27 we come
      👍️0
      TheFinalCD TheFinalCD 3 years ago
      WOW $7 MOVE 3-10


      CONGRAT$ NVCT
      👍️0
      spindog spindog 3 years ago
      I feel the same
      👍️0
      kkballa kkballa 3 years ago
      hmmm.
      👍️0

      Your Recent History

      NASDAQ
      NVCT
      Nuvectis Pharma
      NASDAQ
      FEEQX
      Bmo Selecttrust Conserva...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads